nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirenzepine—CHRM1—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.00925	0.0111	CbGpPWpGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.00925	0.0111	CbGpPWpGaD
Pirenzepine—CHRM5—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00921	0.011	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00882	0.0105	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—GRK6—Parkinson's disease	0.00882	0.0105	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—GRK5—Parkinson's disease	0.00865	0.0103	CbGpPWpGaD
Pirenzepine—Acetophenazine—DRD1—Parkinson's disease	0.00854	0.0523	CrCbGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.00804	0.00961	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.00774	0.00925	CbGpPWpGaD
Pirenzepine—CHRM1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.00771	0.00921	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00756	0.00903	CbGpPWpGaD
Pirenzepine—CHRM1—Calcium Regulation in the Cardiac Cell—GRK5—Parkinson's disease	0.00731	0.00873	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.00719	0.00859	CbGpPWpGaD
Pirenzepine—CHRM5—Regulation of Actin Cytoskeleton—FGF20—Parkinson's disease	0.00658	0.00786	CbGpPWpGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00648	0.00775	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—GRM5—Parkinson's disease	0.00625	0.00747	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00621	0.00742	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.00609	0.00728	CbGpPWpGaD
Pirenzepine—Acetophenazine—DRD2—Parkinson's disease	0.00602	0.0369	CrCbGaD
Pirenzepine—Mirtazapine—HTR7—Parkinson's disease	0.00594	0.0364	CrCbGaD
Pirenzepine—CHRM5—GPCR ligand binding—GPR37—Parkinson's disease	0.00576	0.00688	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00559	0.00668	CbGpPWpGaD
Pirenzepine—Mirtazapine—DRD3—Parkinson's disease	0.00558	0.0342	CrCbGaD
Pirenzepine—Olanzapine—HTR7—Parkinson's disease	0.00558	0.0342	CrCbGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.00545	0.00651	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00532	0.00636	CbGpPWpGaD
Pirenzepine—Olanzapine—DRD3—Parkinson's disease	0.00525	0.0321	CrCbGaD
Pirenzepine—Mirtazapine—SLC6A3—Parkinson's disease	0.0052	0.0318	CrCbGaD
Pirenzepine—Olanzapine—DRD1—Parkinson's disease	0.00515	0.0316	CrCbGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00487	0.00582	CbGpPWpGaD
Pirenzepine—Thioproperazine—DRD1—Parkinson's disease	0.00474	0.029	CrCbGaD
Pirenzepine—CHRM1—Circadian rythm related genes—DDC—Parkinson's disease	0.00473	0.00566	CbGpPWpGaD
Pirenzepine—Thiothixene—DRD1—Parkinson's disease	0.00466	0.0286	CrCbGaD
Pirenzepine—CHRM1—Regulation of Actin Cytoskeleton—FGF20—Parkinson's disease	0.00463	0.00553	CbGpPWpGaD
Pirenzepine—Mirtazapine—HTR1A—Parkinson's disease	0.00455	0.0279	CrCbGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00454	0.00543	CbGpPWpGaD
Pirenzepine—Prochlorperazine—DRD3—Parkinson's disease	0.00454	0.0278	CrCbGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00446	0.00532	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.0044	0.00526	CbGpPWpGaD
Pirenzepine—Olanzapine—HTR1A—Parkinson's disease	0.00428	0.0262	CrCbGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00411	0.00491	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00406	0.00486	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—GPR37—Parkinson's disease	0.00405	0.00484	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00403	0.00482	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00394	0.00471	CbGpPWpGaD
Pirenzepine—Thioproperazine—HTR1A—Parkinson's disease	0.00393	0.0241	CrCbGaD
Pirenzepine—CHRM5—GPCR ligand binding—GRM4—Parkinson's disease	0.00391	0.00468	CbGpPWpGaD
Pirenzepine—Thiothixene—HTR1A—Parkinson's disease	0.00387	0.0237	CrCbGaD
Pirenzepine—Mirtazapine—DRD2—Parkinson's disease	0.00386	0.0237	CrCbGaD
Pirenzepine—CHRM5—GPCR ligand binding—PENK—Parkinson's disease	0.00371	0.00443	CbGpPWpGaD
Pirenzepine—Olanzapine—DRD2—Parkinson's disease	0.00363	0.0222	CrCbGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.0036	0.00431	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00357	0.00426	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.00353	0.00422	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00352	0.00421	CbGpPWpGaD
Pirenzepine—Loxapine—HTR7—Parkinson's disease	0.00347	0.0213	CrCbGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00345	0.00412	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00343	0.0041	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—PDYN—Parkinson's disease	0.00339	0.00405	CbGpPWpGaD
Pirenzepine—Thioproperazine—DRD2—Parkinson's disease	0.00334	0.0205	CrCbGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00334	0.00399	CbGpPWpGaD
Pirenzepine—Thiothixene—DRD2—Parkinson's disease	0.00329	0.0201	CrCbGaD
Pirenzepine—Loxapine—DRD3—Parkinson's disease	0.00326	0.02	CrCbGaD
Pirenzepine—CHRM5—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00325	0.00389	CbGpPWpGaD
Pirenzepine—Loxapine—DRD1—Parkinson's disease	0.0032	0.0196	CrCbGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.0032	0.00382	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—GRM5—Parkinson's disease	0.00315	0.00377	CbGpPWpGaD
Pirenzepine—Prochlorperazine—DRD2—Parkinson's disease	0.00314	0.0192	CrCbGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00314	0.00375	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00313	0.00373	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00306	0.00365	CbGpPWpGaD
Pirenzepine—Loxapine—SLC6A3—Parkinson's disease	0.00303	0.0186	CrCbGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00302	0.00361	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00302	0.00361	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00301	0.0036	CbGpPWpGaD
Pirenzepine—Mirtazapine—HTR2A—Parkinson's disease	0.00299	0.0183	CrCbGaD
Pirenzepine—CHRM1—Circadian rythm related genes—DRD1—Parkinson's disease	0.00296	0.00354	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—DGKQ—Parkinson's disease	0.00295	0.00353	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—GPR37—Parkinson's disease	0.00295	0.00353	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00295	0.00353	CbGpPWpGaD
Pirenzepine—Clozapine—HTR7—Parkinson's disease	0.00291	0.0178	CrCbGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00289	0.00346	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—DRD3—Parkinson's disease	0.00287	0.00343	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00286	0.00342	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00286	0.00342	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00284	0.00339	CbGpPWpGaD
Pirenzepine—Olanzapine—HTR2A—Parkinson's disease	0.0028	0.0172	CrCbGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.0028	0.00334	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—GRM4—Parkinson's disease	0.00276	0.00329	CbGpPWpGaD
Pirenzepine—Clozapine—DRD3—Parkinson's disease	0.00274	0.0168	CrCbGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00273	0.00327	CbGpPWpGaD
Pirenzepine—Mirtazapine—CYP2D6—Parkinson's disease	0.00273	0.0167	CrCbGaD
Pirenzepine—CHRM5—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.0027	0.00323	CbGpPWpGaD
Pirenzepine—Clozapine—DRD1—Parkinson's disease	0.00269	0.0165	CrCbGaD
Pirenzepine—CHRM5—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00268	0.00321	CbGpPWpGaD
Pirenzepine—Trifluoperazine—HTR1A—Parkinson's disease	0.00267	0.0164	CrCbGaD
Pirenzepine—Loxapine—HTR1A—Parkinson's disease	0.00266	0.0163	CrCbGaD
Pirenzepine—CHRM1—Circadian rythm related genes—TH—Parkinson's disease	0.00264	0.00315	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—PENK—Parkinson's disease	0.00261	0.00312	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—HTR7—Parkinson's disease	0.00259	0.0031	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—DRD2—Parkinson's disease	0.00259	0.0031	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00259	0.00309	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00259	0.00309	CbGpPWpGaD
Pirenzepine—Thioproperazine—HTR2A—Parkinson's disease	0.00258	0.0158	CrCbGaD
Pirenzepine—Olanzapine—CYP2D6—Parkinson's disease	0.00256	0.0157	CrCbGaD
Pirenzepine—Thiothixene—HTR2A—Parkinson's disease	0.00254	0.0156	CrCbGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00254	0.00303	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00251	0.003	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00248	0.00296	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—GRK5—Parkinson's disease	0.00247	0.00295	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00245	0.00292	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00243	0.0029	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—PDYN—Parkinson's disease	0.00239	0.00285	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00235	0.00281	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—HTR1A—Parkinson's disease	0.00233	0.00278	CbGpPWpGaD
Pirenzepine—Thiothixene—CYP2D6—Parkinson's disease	0.00232	0.0142	CrCbGaD
Pirenzepine—CHRM5—GPCR ligand binding—TAC1—Parkinson's disease	0.00229	0.00274	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00229	0.00274	CbGpPWpGaD
Pirenzepine—Trifluoperazine—DRD2—Parkinson's disease	0.00227	0.0139	CrCbGaD
Pirenzepine—Loxapine—DRD2—Parkinson's disease	0.00226	0.0138	CrCbGaD
Pirenzepine—CHRM5—GPCR ligand binding—DRD1—Parkinson's disease	0.00225	0.00269	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—GRK5—Parkinson's disease	0.00224	0.00268	CbGpPWpGaD
Pirenzepine—Clozapine—HTR1A—Parkinson's disease	0.00223	0.0137	CrCbGaD
Pirenzepine—CHRM1—GPCR ligand binding—GRM5—Parkinson's disease	0.00222	0.00265	CbGpPWpGaD
Pirenzepine—Prochlorperazine—CYP2D6—Parkinson's disease	0.00222	0.0136	CrCbGaD
Pirenzepine—CHRM5—GPCR downstream signaling—GRM4—Parkinson's disease	0.00221	0.00264	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.0022	0.00263	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—DRD3—Parkinson's disease	0.00218	0.0026	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00215	0.00257	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00212	0.00254	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00212	0.00254	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00212	0.00253	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00211	0.00253	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—VPS35—Parkinson's disease	0.00211	0.00252	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PENK—Parkinson's disease	0.0021	0.00251	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00208	0.00249	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—GPR37—Parkinson's disease	0.00208	0.00249	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00208	0.00248	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00207	0.00247	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00201	0.00241	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—GRM4—Parkinson's disease	0.00201	0.0024	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—HTR7—Parkinson's disease	0.00197	0.00235	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—DRD2—Parkinson's disease	0.00197	0.00235	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00197	0.00235	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00192	0.0023	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PDYN—Parkinson's disease	0.00192	0.00229	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PENK—Parkinson's disease	0.0019	0.00228	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.0019	0.00227	CbGpPWpGaD
Pirenzepine—Clozapine—DRD2—Parkinson's disease	0.00189	0.0116	CrCbGaD
Pirenzepine—CHRM1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00189	0.00226	CbGpPWpGaD
Pirenzepine—Olanzapine—ABCB1—Parkinson's disease	0.00183	0.0112	CrCbGaD
Pirenzepine—Clozapine—CYP2E1—Parkinson's disease	0.00182	0.0112	CrCbGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00182	0.00218	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00182	0.00218	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00181	0.00216	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—GRM5—Parkinson's disease	0.00178	0.00213	CbGpPWpGaD
Pirenzepine—Trifluoperazine—HTR2A—Parkinson's disease	0.00175	0.0108	CrCbGaD
Pirenzepine—CHRM5—Signaling Pathways—DGKQ—Parkinson's disease	0.00175	0.00209	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GPR37—Parkinson's disease	0.00175	0.00209	CbGpPWpGaD
Pirenzepine—Loxapine—HTR2A—Parkinson's disease	0.00174	0.0107	CrCbGaD
Pirenzepine—CHRM5—Signaling by GPCR—PDYN—Parkinson's disease	0.00174	0.00208	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00174	0.00207	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00172	0.00206	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00164	0.00196	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—GRM5—Parkinson's disease	0.00162	0.00193	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.00161	0.00193	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PPP1R1B—Parkinson's disease	0.0016	0.00191	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.00158	0.00189	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.00158	0.00188	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—EDN1—Parkinson's disease	0.00158	0.00188	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00156	0.00186	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.00153	0.00183	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00152	0.00181	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00149	0.00178	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—VPS35—Parkinson's disease	0.00148	0.00177	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.00148	0.00176	CbGpPWpGaD
Pirenzepine—Clozapine—HTR2A—Parkinson's disease	0.00146	0.00897	CrCbGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00146	0.00174	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.00141	0.00169	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—RIT2—Parkinson's disease	0.0014	0.00167	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.00139	0.00166	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.00139	0.00166	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—HTR2A—Parkinson's disease	0.00138	0.00165	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00138	0.00164	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00135	0.00161	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PENK—Parkinson's disease	0.00134	0.0016	CbGpPWpGaD
Pirenzepine—Clozapine—CYP2D6—Parkinson's disease	0.00134	0.0082	CrCbGaD
Pirenzepine—CHRM5—Signaling Pathways—GRK5—Parkinson's disease	0.00132	0.00158	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00132	0.00157	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—TAC1—Parkinson's disease	0.0013	0.00155	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00127	0.00152	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—DRD1—Parkinson's disease	0.00127	0.00152	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00126	0.0015	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—DRD3—Parkinson's disease	0.00123	0.00147	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.00123	0.00147	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GPR37—Parkinson's disease	0.00123	0.00147	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.00123	0.00147	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—HTR1A—Parkinson's disease	0.00119	0.00143	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GRM4—Parkinson's disease	0.00119	0.00142	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—TAC1—Parkinson's disease	0.00118	0.00141	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—DRD1—Parkinson's disease	0.00115	0.00138	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00115	0.00137	CbGpPWpGaD
Pirenzepine—Trifluoperazine—ABCB1—Parkinson's disease	0.00115	0.00702	CrCbGaD
Pirenzepine—CHRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.00114	0.00136	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PENK—Parkinson's disease	0.00112	0.00134	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MAG—Parkinson's disease	0.00112	0.00134	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00112	0.00134	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—DRD3—Parkinson's disease	0.00112	0.00133	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—DRD2—Parkinson's disease	0.00111	0.00133	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—HTR7—Parkinson's disease	0.00111	0.00133	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.00111	0.00133	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00107	0.00128	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00104	0.00125	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PDYN—Parkinson's disease	0.00103	0.00123	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—HTR7—Parkinson's disease	0.00101	0.00121	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—DRD2—Parkinson's disease	0.00101	0.00121	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000987	0.00118	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000982	0.00117	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000971	0.00116	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000969	0.00116	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GFAP—Parkinson's disease	0.000967	0.00116	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—GRM5—Parkinson's disease	0.000956	0.00114	CbGpPWpGaD
Pirenzepine—Clozapine—ABCB1—Parkinson's disease	0.000956	0.00586	CrCbGaD
Pirenzepine—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.000931	0.00111	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000926	0.00111	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000912	0.00109	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000894	0.00107	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—EDN1—Parkinson's disease	0.000891	0.00106	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000866	0.00104	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000849	0.00101	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000841	0.001	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—FGF20—Parkinson's disease	0.000839	0.001	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000835	0.000998	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000828	0.00099	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADORA2A—Parkinson's disease	0.000813	0.000972	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000812	0.000971	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—EDN1—Parkinson's disease	0.000809	0.000967	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000809	0.000967	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.000792	0.000946	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.000792	0.000946	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000787	0.00094	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000783	0.000936	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000783	0.000936	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000779	0.000931	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—INSR—Parkinson's disease	0.00075	0.000897	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000734	0.000878	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000724	0.000865	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000711	0.00085	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000711	0.00085	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—FGB—Parkinson's disease	0.000709	0.000848	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—HTR2A—Parkinson's disease	0.000708	0.000846	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HTR1A—Parkinson's disease	0.000706	0.000843	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TAC1—Parkinson's disease	0.000695	0.00083	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—DRD1—Parkinson's disease	0.000681	0.000814	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000681	0.000814	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000673	0.000805	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—DRD3—Parkinson's disease	0.00066	0.000789	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000631	0.000754	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000627	0.000749	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—ADRBK1—Parkinson's disease	0.000616	0.000736	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000597	0.000714	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HTR7—Parkinson's disease	0.000597	0.000713	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—DRD2—Parkinson's disease	0.000597	0.000713	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.00059	0.000706	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000573	0.000684	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.00057	0.000681	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000549	0.000656	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.000528	0.000631	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	0.0005	0.000598	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000499	0.000597	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000498	0.000595	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000497	0.000594	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000489	0.000585	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	0.000484	0.000578	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.00048	0.000573	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	0.000478	0.000571	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000465	0.000555	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NGF—Parkinson's disease	0.000439	0.000525	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000434	0.000518	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.00042	0.000502	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.00042	0.000502	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	0.000418	0.0005	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—APOE—Parkinson's disease	0.000389	0.000464	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000352	0.000421	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.00034	0.000407	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000336	0.000402	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—INS—Parkinson's disease	0.000332	0.000397	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.000309	0.000369	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000294	0.000352	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	0.000274	0.000327	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	0.000247	0.000295	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	0.000246	0.000293	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—INS—Parkinson's disease	0.000234	0.000279	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	0.000227	0.000271	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	0.000174	0.000208	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000173	0.000207	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	0.00016	0.000191	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—IL6—Parkinson's disease	0.000145	0.000173	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	0.000102	0.000122	CbGpPWpGaD
